If you need more lookups,
subscriptions start at $34 USD/month.
Nadia Agopyan Location
Thousand Oaks, CA, US
Nadia Agopyan Work
Senior Vice President @ (March 2024 - Present)
Senior Vice President @ (November 2021 - March 2024)
Head Of Regulatory Affairs @ (August 2019 - March 2024)
Vice President @ (August 2019 - December 2021)
Chief member @ (June 2021 - March 2024)
Global Regulatory Affairs @ (April 2015 - July 2019)
Global Regulatory Affairs @ (February 2012 - April 2015)
Senior Director Regulatory Affairs @ Ambit Biosciences (May 2010 - February 2012)
Director Regulatory Affairs @ (July 2009 - May 2010)
Director Regulatory Affairs and Operations @ Cougar biotechnology (May 2006 - May 2010)
Manager @ (January 2005 - April 2006)
Regulatory Scientist @ Cato Research (January 2003 - January 2005)
Assistant Professor @ (January 2000 - January 2003)
Research Scientist @ NPSP-Allelix Biopharmaceuticals (January 1998 - January 2000)
Assistant Professor @ (January 1996 - January 2000)
Research Scientist @ Mount Sinai Hospital (January 1995 - December 1996)
Research Scientist @ (January 1994 - December 1994)
Research Scientist @ Max Planck Institute fur Medzinische Forshung (January 1992 - December 1993)
Research Scientist @ (November 1990 - December 1991)
Nadia Agopyan Education
McGill University
Ph.D. (Physiology/Neurophysiology)
1984-1990
McGill University
B.Sc. (Physiology)
1980-1984
English High School
Science
1972-1980
Nadia Agopyan Skills
Biopharmaceuticals
Biotechnology
CRO
CTMS
Clinical Development
Clinical Research
Clinical Study Design
Clinical Trials
Drug Development
FDA
GCP
IND
Immunology
Leadership
Life Sciences
Lifesciences
NDA
Neuroscience
Oncology
Pharmaceutical Industry
Product Development
Project Management
Protocol
Regulatory Affairs
Regulatory Submissions
SOP
Strategic Planning
Strategy
U.S. Food and Drug Administration (FDA)
eCTD
Molecular Biology
PowerPoint
Teaching
Biochemistry
Science
Nadia Agopyan Summary
Nadia Agopyan, based in Thousand Oaks, CA, US, is currently a Senior Vice President at Neurona Therapeutics. Nadia Agopyan brings experience from previous roles at Marker Therapeutics, Inc. and Chief. Nadia Agopyan holds a 1984 - 1990 Ph.D. in Physiology/Neurophysiology @ McGill University. With a robust skill set that includes Biopharmaceuticals, Biotechnology, CRO, CTMS, Clinical Development and more. Nadia Agopyan has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Nadia Agopyan?
Find contact details for 700 million professionals.